Shareholder alert - the m&a class action firm announces an investigation of biohaven pharmaceutical holding company ltd. - bhvn

New york , may 13, 2022 /prnewswire/ --  juan monteverde , founder and managing partner of the class action firm monteverde & associates pc (the "m&a class action firm"), a national securities firm rated top 50 in the 2018-2021 iss securities class action services report and headquartered at the empire state building in new york city, is investigating biohaven pharmaceutical holding company ltd. (bhvn), relating to its proposed merger with pfizer inc. under the terms of the agreement, bhvn shareholders will receive 0.5 shares of new biohaven and $148.50 in cash per share.
BHVN Ratings Summary
BHVN Quant Ranking